Hepatitis C Information Central


Discover the latest news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information

News, Updates and Commentary

Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

77 more hepatitis cases may trace to clinic, officials say
LAS VEGAS -- Seventy-seven more people that were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said. Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist

77 more hepatitis cases may trace to clinic at center of Las Vegas outbreak, officials say
AM LAS VEGAS-Seventy-seven more people that were treated at a Las Vegas outpatient clinic accused of reusing syringes on thousands of people have been diagnosed with Hepatitis C, health officials said. Authorities cannot say for sure how the 77 people

77 more hepatitis cases may trace to clinic, officials say
Seventy-seven more people that were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said.Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist with the


UPDATES AND COMMENTARY RSS Feed

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...

Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...

Hepatitis C Complications Helped by Maintenance Interferon
A four-year study confirms that low-dosage maintenance interferon therapy prevents disease progression in those with portal hypertension or cirrhosis from Hepatitis C....

Hepatology, Vol 24, 1003-1009, Copyright © 1996 by American Association for the Study of Liver Diseases

Phylogenetic analysis of Hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology

S Zeuzem, A Franke, JH Lee, G Herrmann, B Ruster and WK Roth  Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe- Universitat, Frankfurt, Germany.

Nucleotide sequence analysis of Hepatitis C virus (HCV) strains showed substantial variability leading to a classification into several genotypes and subtypes. The data correlating HCV genotypes and subtypes with Hepatitis C viremia levels, demographic characteristics of patients (age, mode of transmission, duration of infection), and severity of liver disease are conflicting. The interpretation of several studies is further complicated because the molecular methods used lacked specificity for genotyping/subtyping and underestimated viremia levels, especially in patients infected with HCV genotypes 2 and 3. In the present study we investigated 97 consecutive patients with chronic Hepatitis C using molecular "gold standard" methods. HCV subtyping was performed by sequence and phylogenetic analysis of the nonstructural (NS)-5 region and serum HCV-RNA concentration was assessed by a validated genotype-independent quantitative reverse- transcription-polymerase chain reaction assay using an internal RNA standard. Patients infected with subtypes HCV-1b, HCV-2a-c, and HCV-4 were older than patients infected with HCV-1a and HCV-3a. Serum HCV-RNA levels ranged from 1.5 x 10(4) to 1.0 x 10(8) copies/mL with no significant differences between median serum HCV-RNA concentrations in patients infected with different genotypes/subtypes. Although patients infected with HCV-1b were older, no biochemical or histological evidence was obtained that this subtype is associated with more severe liver disease. Furthermore, the present study showed a lack of correlation between the serum HCV-RNA concentration, biochemical parameters, and liver histology. The median serum HCV-RNA levels in patients with chronic persistent hepatitis, chronic active hepatitis, and liver cirrhosis were 5.0 x 10(6) copies/mL, 2.5 x 10(6) copies/mL, and 5.0 x 10(6) copies/mL, respectively. These differences were not significant. In conclusion, using optimized and validated molecular techniques, the present cross-sectional study showed no correlation between HCV genotypes/subtypes, viremia, liver function test results, and histology.

This article has been cited by other articles:

Zeuzem, S., Lee, J.-H., Franke, A., Rüster, B., Prümmer, O., Herrmann, G., Roth, W. K. (1998). Quantification of the Initial Decline of Serum Hepatitis C Virus RNA and Response to Interferon Alfa. Hepatology 27: 1149-1156

Pessione, F., Degos, F., Marcellin, P., Duchatelle, V., Njapoum, C., Martinot-Peignoux, M., Degott, C., Valla, D., Erlinger, S., Rueff, B. (1998). Effect of Alcohol Consumption on Serum Hepatitis C Virus RNA and Histological Lesions in Chronic Hepatitis C. Hepatology 27: 1717-1722

Zeuzem, S., Schmidt, J. M., Lee, J.-h., von Wagner, M., Teuber, G., Roth, W. K. (1998). Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover. Hepatology 28: 245-252 [Full Text]

Abe, K., Edamoto, Y., Park, Y. N., Nomura, A. M. Y., Taltavull, T. C., Tani, M., Thung, S. N. (1998). In Situ Detection of Hepatitis B, C, and G Virus Nucleic Acids in Human Hepatocellular Carcinoma Tissues from Different Geographic Regions. Hepatology 28: 568-572

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 09 May 2008